SVA
Sinovac Biotech, Ltd
SVA
SVA
Delisted
SVA was delisted on the 22nd of February, 2019.
35 hedge funds and large institutions have $70.4M invested in Sinovac Biotech, Ltd in 2013 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
6% more funds holding
Funds holding: 33 → 35 (+2)
Holders
35
Holding in Top 10
–
Calls
$697K
Puts
$281K
Top Buyers
| 1 | +$3.01M | |
| 2 | +$1.32M | |
| 3 | +$1.01M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$644K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$548K |
Top Sellers
| 1 | -$6.9M | |
| 2 | -$1.76M | |
| 3 | -$169K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$141K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
-$104K |